Cellectis
Developing allogeneic CAR-T therapies
- B2B
- Has physical offices
- Publicly traded
- Healthtech
- Sales-led purchase
About Cellectis
Innovative biopharmaceutical company developing off-the-shelf CAR-T immunotherapies to treat cancer utilizing gene editing technology and immune system targeting
Key facts
- Industry
- Biotechnology Research
- Company size
- 51–250 employees
- Headquarters
- Paris, Île-de-France, France
- Founded
- 1999
- Revenue
- $72.9MFY2025, publicly reported
- SIREN
- 428859052
- Website
- cellectis.com
- linkedin.com/company/cellectis
Cellectis at a glance
Cellectis is a B2B company in the Biotechnology Research industry, headquartered in Paris, Île-de-France, France.
Cellectis was founded in 1999.
Cellectis has 51–250 employees.
Cellectis's revenue is $72.9M (FY2025, publicly reported).
Cellectis's SIREN number is 428859052.
Selling to companies like Cellectis?
Tamtam finds the companies that match your ideal customer, researches each account and tells you who to contact and when.
Find similar companies